Pharmaceutical company «Darnitsa»

Цей текст також доступний українською Этот текст также доступен на русском
Darnitsa is the national producer of medicines. Cardiology, neurology, and pain syndrome are among its strategic priorities.

Pharmaceutical company «Darnitsa» stories

Company authors

About the company

The company has come a long way from a Soviet enterprise to a modern hi-tech pharmaceutical plant. Over the past decade, Darnitsa modernized all its core and ancillary manufacturing facilities, built a robotic warehouse complex for 10,000 pallet positions, invested over €200 million in production, implemented an automated manufacturing planning system, and obtained a GMP certificate.

Such an approach allowed Darnitsa to take the lead among national pharmaceutical producers and become number one in the sales of prepackaged medications in Ukraine.

Pharmaceutical company «Darnitsa» on Mind

Company news

Darnitsa is the first Ukrainian company to join The Regulatory Affairs Professionals Society

This is the largest global organization of professionals involved with the regulation of healthcare and related products
Special Project

Healthy planet: how to take care of people and the environment at the same time

Darnitsa ecologist tells how the company was creating its ecosystem and managed to involve employees in responsible waste management
Special Project

Billions against epidemic: how pharmaceutical world is weathering the crisis

And why pharmacists spare no money on innovation

«Darnitsa» increases its net profit by 31%

No dividends will be paid. The net profit of UAH 449 134 thousands will be reinvested for the companys financial needs

Life Elixir: how a pharmaceutical company launched the production of infusions

And why is it unique for Ukraine.

General director of pharmaceutical firm “Darnitsa”: “Import substitution is nothing more than another form of competition”

Svitlana Didenko speaks about market realities, public interests, patients’ preferences and the company’s readiness for the healthcare reform